OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Integrative multi-omic cancer profiling reveals DNA methylation patterns associated with therapeutic vulnerability and cell-of-origin
Wen-Wei Liang, Rita Jui-Hsien Lu, Reyka G. Jayasinghe, et al.
Cancer Cell (2023) Vol. 41, Iss. 9, pp. 1567-1585.e7
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets
Shaosen Zhang, Xinyi Xiao, Yonglin Yi, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 53

Graph machine learning for integrated multi-omics analysis
Nektarios A. Valous, Ferdinand Popp, Inka Zörnig, et al.
British Journal of Cancer (2024) Vol. 131, Iss. 2, pp. 205-211
Open Access | Times Cited: 14

Comparison of spatial transcriptomics technologies across six cancer types
Sergi Cervilla, Daniela Grases, Elena E. Perez, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 10

Epigenomic insights into common human disease pathology
Christopher G. Bell
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 9

Unveiling DNA methylation: early diagnosis, risk assessment, and therapy for endometrial cancer
Minzhen Li, Zhili Xia, Ruiyu Wang, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access | Times Cited: 1

Advancements in proteogenomics for preclinical targeted cancer therapy research
Yuying Suo, Yuanli Song, Yuqiu Wang, et al.
Biophysics Reports (2025) Vol. 11, Iss. 1, pp. 56-56
Open Access

Epigenetic Modification and Tumor Immunity: Unraveling the Interplay with the Tumor Microenvironment and its Therapeutic Vulnerability and Implications
Huaijin Zheng, Yuze Hua, Sen Yang, et al.
Cancer Letters (2025) Vol. 616, pp. 217587-217587
Closed Access

Integrative genome-wide aberrant DNA methylation and transcriptome analysis identifies diagnostic markers for colorectal cancer
Hengyang Shen, Zhenling Wang, Yang Chen, et al.
Archives of Toxicology (2025)
Closed Access

The Regulation of Cellular Senescence in Cancer
Xianhong Zhang, Yue Gao, Shanpeng Zhang, et al.
Biomolecules (2025) Vol. 15, Iss. 3, pp. 448-448
Open Access

BAP1-mediated MAFF deubiquitylation regulates tumor growth and is associated with adverse outcomes in colorectal cancer
Zhongdong Xie, Hanbin Lin, Ying Huang, et al.
European Journal of Cancer (2024) Vol. 210, pp. 114278-114278
Closed Access | Times Cited: 4

DNA methylation profiles in cancer: functions, therapy, and beyond
Jinrong Zhu, Jian Yang, Li Li, et al.
Cancer Biology and Medicine (2023), pp. 1-6
Open Access | Times Cited: 10

Functional mapping of epigenetic regulators uncovers coordinated tumor suppression by the HBO1 and MLL1 complexes
Yuning J. Tang, Haiqing Xu, Nicholas W. Hughes, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2

BioXNet: a biologically inspired neural network for deciphering anti-cancer drug response in precision medicine
Jiannan Yang, William K.K. Wu, Rina Yee Man Hui, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1

Tissue of origin prediction for cancer of unknown primary using a targeted methylation sequencing panel
Miaomiao Sun, Bo Xu, Chao Chen, et al.
Clinical Epigenetics (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 1

Regulatory effect of N6-methyladenosine on tumor angiogenesis
Yuyan, Enwu Yuan
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1

Advances and current research status of early diagnosis for gallbladder cancer
Jiajia He, Wei-Lv Xiong, Wei-Qi Sun, et al.
Hepatobiliary & pancreatic diseases international (2024)
Closed Access | Times Cited: 1

Comprehensive bioinformatics analysis of human cytomegalovirus pathway genes in pan-cancer
Tengyue Yan, Xianwu Pang, Boying Liang, et al.
Human Genomics (2024) Vol. 18, Iss. 1
Open Access

Integrated profiling identifies DXS253E as a potential prognostic marker in colorectal cancer
Pu Xing, Hao Hao, Jiangbo Chen, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access

The Landscape and Function of Tissue-Biased Expressed Genes Across Human Cancers
Zhihang Chen, Zhuobin Lin, Hongyan Sun, et al.
(2024)
Closed Access

Enhancing Antitumor Activity of Herceptin in HER2-Positive Breast Cancer Cells: A Novel DNMT-1 Inhibitor Approach
Lili Ren, Yan-ru Song, Zhenchuan Song, et al.
Research Square (Research Square) (2024)
Open Access

Unraveling the mysteries of MGMT: Implications for neuroendocrine tumors
JianyunJiang, Junfeng Xu, Shunrong Ji, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024), pp. 189184-189184
Closed Access

DNA Methylation as a Molecular Mechanism of Carcinogenesis in World Trade Center Dust Exposure: Insights from a Structured Literature Review
Stephanie Tuminello, Nedim Durmuş, Matija Snuderl, et al.
Biomolecules (2024) Vol. 14, Iss. 10, pp. 1302-1302
Open Access

Enhancing antitumor activity of herceptin in HER2-positive breast cancer cells: a novel DNMT-1 inhibitor approach
Lili Ren, Yan-ru Song, Zhenchuan Song, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access

Page 1 - Next Page

Scroll to top